About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $2.24 | Open | $2.19 |
| Volume | 791.2K | Market Cap | 30.1M |
| Yield | Last Dividend |
| Hoth Therapeutics : Announces Private Pl... | 01/05/21 |
| NEW YORK, Jan. 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. , a biopharmaceutical company, today announced that it has entered into a definitive se... | |
| Hoth Therapeutics Receives Approval to C... | 12/10/20 |
| NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that is has received Huma... | |
| Hoth Therapeutics Announces Positive, St... | 11/03/20 |
| NEW YORK, Nov. 3, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced positive, statistically si... | |
| The Daily Biotech Pulse: Aurinia Pulls T... | 11/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-... | |
| Hoth Therapeutics (NASDAQ:HOTH) Stock Pr... | 10/24/20 |
| Hoth Therapeutics, Inc. (NASDAQ:HOTH) rose 5% on Friday . The stock traded as high as $1.90 and last traded at $1.88. Approximately 136,445 shares tra... | |
| Hoth Therapeutics Announces USPTO Grant ... | 10/20/20 |
| NEW YORK, Oct. 20, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that through its commerci... | |
| The Daily Biotech Pulse: FDA Nod For Pfi... | 09/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28) 10... | |
| Hoth Therapeutics Enters into Sponsored ... | 09/21/20 |
| NEW YORK , Sept. 21, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH ), a biopharmaceutical company, today announced that it has entered in... | |
| Hoth Therapeutics Appoints Stefanie John... | 08/31/20 |
| NEW YORK, Aug. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announces the appointment of Stefani... | |
| The Daily Biotech Pulse: Altimmune Repor... | 08/25/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT ) Cancer Genetics Inc (NASDAQ: CGIX ) (announced a dea... | |
| Hoth Therapeutics Provides Shareholder U... | 08/19/20 |
| NEW YORK, Aug. 19, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today is providing shareholders with a up... | |
| Hoth Therapeutics Executes Licensing Agr... | 07/31/20 |
| NEW YORK, July 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has executed a licensi... | |
| The Daily Biotech Pulse: Novartis Settle... | 07/02/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) AbbV... | |
| Hoth Therapeutics' Scientific Advisory B... | 06/15/20 |
| NEW YORK, June 15, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Scientific Advisory ... | |
| Hoth Therapeutics Receives Notice of All... | 06/08/20 |
| NEW YORK, June 8, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that the United States Pat... | |
| Hoth Therapeutics Announces Closing of P... | 05/27/20 |
| NEW YORK, May 27, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. ("Hoth" or the "Company") (NASDAQ: HOTH), a biopharmaceutical company, announced today ... | |
| Hoth Therapeutics Announces the Appointm... | 05/22/20 |
| NEW YORK, May 22, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Michael H. Peters, Ph... | |
| Hoth Therapeutics Licenses Novel Peptide... | 05/20/20 |
| NEW YORK, May 20, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced licensing technology and i... | |
| Hoth Therapeutics Procures Full Licensin... | 05/18/20 |
| NEW YORK, May 18, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced today that the company has... | |
| Hoth Therapeutics, Inc., Voltron Therape... | 04/24/20 |
| NEW YORK, April 24, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) announced today that Voltron Therapeutics, Inc has selected the peptid... | |
| Hoth Therapeutics Announces Top Line Pre... | 04/21/20 |
| NEW YORK, April 21, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced top line data from its C... | |
| Hoth Therapeutics Announces Additions to... | 04/17/20 |
| NEW YORK, April 17, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced the addition of two inde... | |
| Hoth Therapeutics Enters into Letter of ... | 03/30/20 |
| NEW YORK , March 30, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH ), a biopharmaceutical company, today announced it has entered into a ... | |
| Hoth Drops on Stock Offering | 03/24/20 |
| Hoth Therapeutics, Inc. (NASDAQ:HOTH) subsided Tuesday morning on revealing a proposed common stock offering. The company???s shares jumped around 39%... | |
| Hoth Therapeutics, Inc. Announces Propos... | 03/23/20 |
| NEW YORK, March 23, 2020 /PRNewswire/ -- Hoth Therapeutics Inc. (Nasdaq: HOTH) ("Hoth" or the "Company"), a biopharmaceutical company, today announced... | |
| Hoth Therapeutics Shares Jump On COVID-1... | 03/23/20 |
| Hoth Therapeutics Inc (NASDAQ: HOTH ) shares were roaring higher Monday after the biopharma announced its foray into COVID-19 vaccine development, joi... | |
| The Daily Biotech Pulse: Mylan Ramps Up ... | 03/20/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) ... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 66.00 % | Follow |
| R R Investments | Roland Van Rij | 39.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.